FibroGen Stock (NASDAQ: FGEN) stock price, news, charts, stock research, profile.
Open | $0.40 |
Close | $0.40 |
Volume / Avg. | 950.55K / 2.59M |
Day Range | $0.39 - $0.42 |
52 Wk Range | 0.33 - 2.93 |
Market Cap | $40.77M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 33 |
Short Interest | 5.91% |
Days to Cover | 1.46 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of FibroGen (NASDAQ:FGEN) through any online brokerage.
Other companies in FibroGen’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Acurx Pharmaceuticals (NASDAQ:ACXP), OncoCyte (NASDAQ:OCX), Curis (NASDAQ:CRIS) and Aligos Therapeutics (NASDAQ:ALGS).
FibroGen has a consensus price target of $10.00.
The stock price for FibroGen (NASDAQ: FGEN) is $0.4061 last updated August 23, 2024 at 7:11 PM EDT.
There are no upcoming dividends for FibroGen.
FibroGen’s Q3 earnings are confirmed for Monday, November 4, 2024.
There is no upcoming split for FibroGen.
FibroGen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.